TWDBTaiwan Manufacturer Database 中文

PHARMIGENE, INC.

世基生物醫學股份有限公司

Get an email when something changes (or just keep it in this browser without an email).

My watchlist →

2005Founded
NT$505MPaid-in capital
1Plants
13Certifications
NT$100–500MRevenue band
Unified Business No.
27953682
Industry
Pharmaceuticals & Medicinal Chemicals (273)
Main products
Pharmaceuticals & medicinal chemicals (276)
Location
7 F., No. 302, Jianguo 1st Rd., Xinzhuang Dist., New Taipei City 242047, Taiwan (R.O.C.)
New Taipei City (16,829) · Xinzhuang Dist. (2,990)
Listing
Emerging stock (TPEx) (359) 7595
Organisation type
Company Limited by Shares
Founded
2005-09-28
Paid-in capital
NT$ 504,650,000
Representative
Tsai Shih-chen
Phone
(02)2798-5885
Website
https://pharmigene.com.tw/
Exporter
Yes — registered with the Trade Administration
Annual revenue band
NT$100–500M
Ownership
Group subsidiary / corporate-held · Lai Ma Technology Co., Ltd.、Taiwan Chin Yueh Co., Ltd.
North American market
FDA medical device registration
Representative tenure
In office since 2025-12 (0 yrs); last handover 2025-12
Growth & profitability
Revenue 2026-09 YoY -45.0%, year-to-date -27.4%
Gross margin 30.6%, operating margin -27.6%, net margin -30% (2026-Q2 YTD)

Certifications 13

Processes & materials 1

North American market evidence 1

  • FDA medical device registration 3006532105 2007-05-01
    Reagents, Specific, Analyte

Public registers of the US FDA, the FCC and Health Canada, matched on the registered English name. An FDA import refusal is a negative record, but also shows goods actually shipped to the US. The FCC dataset ends in 2021.

Government programs & awards 1

  • Startup Award – Quality Award 2008 · Ministry of Economic Affairs Small & Medium Enterprise and Startup Administration

Recent changes 1

  • RepresentativeRepresentative handover — now Tsai Shih-chen

RSS feed · Recent changes at Taiwanese manufacturers →

Similar companies 10

  • PLEXBIO CO., LTD. · Taipei City Emerging stock (TPEx) NT$100–500M
    Shared: Testing & inspection, Medical device license (Class I), Medical device license (Class II), GMP
  • LabTurbo Biotech Corporation · Taipei City Emerging stock (TPEx) NT$100–500M
    Shared: Testing & inspection, Medical device license (Class I), Medical device license (Class II), ISO 13485
  • TTY BIOPHARM COMPANY LIMITED · Taipei City Listed (TPEx) ≥ NT$5B
    Shared: Medical device license (Class II), GMP, ISO 17025
  • SUN TEN PHARMACEUTICAL CO., LTD. · Taichung City NT$0.5–1B estimated
    Shared: Testing & inspection, Medical device license (Class II), GMP, ISO 17025
  • KAISER PHARMACEUTICAL CO., LTD. · Tainan City NT$1–5B estimated
    Shared: Testing & inspection, Medical device license (Class II), GMP, ISO 17025
  • DR. PLATE BIOTECH COMPANY · Taipei City < NT$20M estimated
    Shared: Medical device license (Class I), Medical device license (Class II), Other merchandise wholesale brokerage n.e.c.
  • TAIWAN ADVANCED NANOTECH INC. · Taoyuan City Emerging stock (TPEx) NT$100–500M
    Shared: Medical device license (Class I), Medical device license (Class II), ISO 13485, Other merchandise wholesale brokerage n.e.c.
  • FOXXMED LTD. · Yilan County < NT$20M estimated
    Shared: Medical device license (Class I), Medical device license (Class II)
  • TAIWAN BIOTECH CO., LTD. · Taoyuan City Public company (unlisted) ≥ NT$5B
    Shared: Medical device license (Class I), Medical device license (Class II), GMP, ISO 13485
  • PROTECTLIFE INTERNATIONAL BIOMEDICAL INC. · Taoyuan City < NT$20M estimated
    Shared: Medical device license (Class I), Medical device license (Class II)

Ranked by overlap in processes and materials, registered business activities, certifications and main products; rarer shared traits weigh more. Dissolved companies are excluded.

Open in advanced filters →